BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31552191)

  • 1. Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity.
    Yang XG; Zhu LC; Wang YJ; Li YY; Wang D
    Front Oncol; 2019; 9():887. PubMed ID: 31552191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
    Sun B; Zhang D; Zhao N; Zhao X
    Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review).
    Fan YL; Zheng M; Tang YL; Liang XH
    Oncol Lett; 2013 Nov; 6(5):1174-1180. PubMed ID: 24179490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Chinese medicine as targeted treatment for epithelial-mesenchymal transition-induced cancer progression.
    Liu J; Ke F; Cheng H; Zhou J
    J Cell Biochem; 2019 Feb; 120(2):1068-1079. PubMed ID: 30431663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets.
    Tang H; Chen L; Liu X; Zeng S; Tan H; Chen G
    Front Pharmacol; 2024; 15():1346719. PubMed ID: 38694917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
    Zheng X; Yu C; Xu M
    Front Oncol; 2021; 11():678333. PubMed ID: 34262865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.
    Liu Q; Qiao L; Liang N; Xie J; Zhang J; Deng G; Luo H; Zhang J
    J Cell Mol Med; 2016 Sep; 20(9):1761-9. PubMed ID: 27027258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cell Plasticity - A Deadly Deal.
    Thankamony AP; Saxena K; Murali R; Jolly MK; Nair R
    Front Mol Biosci; 2020; 7():79. PubMed ID: 32426371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial Mesenchymal Transition and Vascular Mimicry in Breast Cancer Stem Cells.
    Kotiyal S; Bhattacharya S
    Crit Rev Eukaryot Gene Expr; 2015; 25(3):269-80. PubMed ID: 26558950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
    Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial Plasticity, Autophagy and Metastasis: Potential Modifiers of the Crosstalk to Overcome Therapeutic Resistance.
    Garg M
    Stem Cell Rev Rep; 2020 Jun; 16(3):503-510. PubMed ID: 32125607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Plasticity-Targeted Therapy in Head and Neck Cancers.
    Shang W; Zhang Q; Huang Y; Shanti R; Alawi F; Le A; Jiang C
    J Dent Res; 2018 Jun; 97(6):654-664. PubMed ID: 29486673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
    Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
    J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer.
    Wu Q; Wang J; Liu Y; Gong X
    Int J Clin Exp Pathol; 2019; 12(5):1678-1689. PubMed ID: 31933986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
    Najafi M; Mortezaee K; Ahadi R
    Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
    Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
    Front Oncol; 2018; 8():203. PubMed ID: 29922594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.